NCT06199895: Clinical Efficacy and Safety of Paclitaxel Polymeric Micelles for Injection in the Treatment of Patients With Taxans-resistant Pancreatic Adenocarcinoma, Cholangiocarcinoma, Lung Cancer, Gastric Cancer, Esophageal Carcinoma, or Breast Cancer
- State
- Under way
- Phase
- Phase 2
- People
- 25 planned
- Started
- 28 Nov 2023
- Primary completion
- Nov 2025
- Arms
- Paclitaxel Polymeric Micelles for Injection
- Results
- None posted
- 28 Nov 2023: Trial started
- 10 Jan 2024: Trial registered